Dev Labtech

  • Market Cap: Micro Cap
  • Industry: Gems, Jewellery And Watches
  • ISIN: INE0NIJ01017
  • NSEID:
  • BSEID: 543848
INR
81.50
1.22 (1.52%)
BSENSE

Dec 03

BSE+NSE Vol: 4000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003820,
    "name": "Dev Labtech",
    "stock_name": "Dev Labtech",
    "full_name": "Dev Labtech Venture Ltd",
    "name_url": "stocks-analysis/dev-labtech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "81.50",
    "chg": 1.22,
    "chgp": "1.52%",
    "dir": 1,
    "prev_price": "80.28",
    "mcapval": "94.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543848,
    "symbol": "",
    "ind_name": "Gems, Jewellery And Watches",
    "ind_code": 37,
    "indexname": "",
    "isin": "INE0NIJ01017",
    "curr_date": "Dec 03",
    "curr_time": "",
    "bse_nse_vol": 4000,
    "exc_status": "Active",
    "traded_date": "Dec 03, 2025",
    "traded_date_str": "2025 12 03",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dev-labtech-1003820-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Dev Labtech overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-dev-labtech-overvalued-or-undervalued-3732791",
        "imagepath": "",
        "date": "2025-11-27 08:51:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Valuation Metrics Indicate Elevated Pricing</strong></p>\n<p>Dev Labtech’s price-to-earnings (PE) ratio stands at an elevated 71.55, significantly higher than the broader market average and many of its industry peers. This high PE ratio suggests that investors are pricing in substantial future growth or are willing to pay a premium for the company’s earnings potential. However, such a lofty multiple also raises concerns about overvaluation, especially when juxtaposed with the company’s modest return on capital employed (ROCE) of 4.35% and return on equity (ROE) of 2.92%, which are relatively low for a firm commanding such a premium.</p>\n<p>The price-to-book (P/B) value of 2.09 further supports the notion that the stock is trading well above its net asset value. Additionally, enterprise value ..."
      },
      {
        "title": "Why is Dev Labtech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dev-labtech-fallingrising-3722306",
        "imagepath": "",
        "date": "2025-11-22 01:29:52",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Dev Labtech's share price increase on 21-Nov reflects a broader trend of strong short-term gains. Over the past week, the stock has surged by 10.96%, significantly outpacing the Sensex's modest 0.79% rise during the same period. This outperformance extends to the one-month horizon, where Dev Labtech has appreciated by 13.18%, compared to the Sensex's 0.95% gain. Despite these encouraging short-term returns, the stock remains in negative territory year-to-date, down 11.81%, and has experienced a 19.01% decline over the last year, contrasting with the Sensex's positive returns of 9.08% and 10.47% respectively. This divergence highlights the stock's recent recovery phase amid a longer-term correction.</p>\n<p><strong>Technical Indicators a..."
      },
      {
        "title": "Why is Dev Labtech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dev-labtech-fallingrising-3709426",
        "imagepath": "",
        "date": "2025-11-17 23:58:59",
        "description": "As of 17-Nov, Dev Labtech Venture Ltd is currently priced at 62.17, reflecting an increase of 0.97 or 1.58%. The stock has shown erratic trading patterns, having not traded on one day out of the last 20 days, which may contribute to its volatility. Despite today's performance, which outperformed its sector by 0.58%, the stock has experienced a decline of 0.70% over the past week and 19.26% year-to-date. Additionally, the delivery volume has significantly decreased by 88.1% compared to the 5-day average, indicating falling investor participation. The stock's moving averages are higher than the 5-day and 20-day averages but lower than the 50-day, 100-day, and 200-day averages, suggesting mixed signals regarding its price momentum.\n\nBroader Market Context: In comparison to the benchmark Sensex, which has gained 1.69% over the past week and 8.72% year-to-date, Dev Labtech's recent performance has lagged behind,..."
      },
      {
        "title": "How has been the historical performance of Dev Labtech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-dev-labtech-3695739",
        "imagepath": "",
        "date": "2025-11-13 00:37:46",
        "description": "Answer:\nThe historical performance of Dev Labtech shows a mixed trend in its financial metrics for the fiscal years ending March 2024 and March 2025.\n\nBreakdown:\nIn the fiscal year ending March 2025, Dev Labtech reported net sales of 52.41 Cr, an increase from 43.22 Cr in March 2024. Total operating income also rose to 52.41 Cr from 43.22 Cr. However, raw material costs surged significantly to 54.39 Cr from just 2.21 Cr the previous year, while the purchase of finished goods dropped to zero from 41.35 Cr. Total expenditure, excluding depreciation, increased to 49.34 Cr from 40.35 Cr. Operating profit (PBDIT) slightly improved to 3.07 Cr from 2.87 Cr, resulting in an operating profit margin of 5.86%, down from 6.64%. Profit before tax increased marginally to 1.85 Cr from 1.83 Cr, while profit after tax decreased to 1.29 Cr from 1.34 Cr. The earnings per share (EPS) fell to 1.14 from 1.62, reflecting a declin..."
      },
      {
        "title": "Is Dev Labtech overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-dev-labtech-overvalued-or-undervalued-3646835",
        "imagepath": "",
        "date": "2025-10-27 08:07:46",
        "description": "As of 24 October 2025, the valuation grade for Dev Labtech has moved from fair to expensive, indicating a significant shift in its perceived value. The company is currently overvalued, with a PE ratio of 56.15, an EV to EBITDA ratio of 23.92, and a Price to Book Value of 1.80. These ratios suggest that the stock is trading at a premium compared to its earnings and book value.\n\nWhen compared to peers, Dev Labtech's valuation stands out as expensive, particularly against Titan Company, which has a PE ratio of 88.77, and Kalyan Jewellers, with a PE ratio of 63.81. In contrast, PC Jeweller, which is rated very attractive, has a significantly lower PE ratio of 13.23. Additionally, Dev Labtech's recent stock performance has been underwhelming, with a year-to-date return of -20.7%, compared to a 7.77% gain in the Sensex, reinforcing the notion that the stock may not be a favorable investment at its current valuati..."
      },
      {
        "title": "Is Dev Labtech overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-dev-labtech-overvalued-or-undervalued-3645871",
        "imagepath": "",
        "date": "2025-10-26 08:07:32",
        "description": "As of 24 October 2025, the valuation grade for Dev Labtech has moved from fair to expensive, indicating a shift in perception regarding its market value. The company is currently deemed overvalued based on its high PE ratio of 56.15 and an EV to EBITDA ratio of 23.92, which are significantly higher than some of its peers. For instance, Titan Company has a PE ratio of 88.77, while Kalyan Jewellers stands at 63.81, both of which are also classified as expensive but still reflect a more favorable valuation compared to Dev Labtech.\n\nThe company's financial metrics further reinforce this overvaluation stance, with a ROCE of only 4.75% and a ROE of 3.20%, suggesting that the returns generated on capital and equity are relatively low. Additionally, the stock has underperformed compared to the Sensex, with a year-to-date return of -20.7% versus the Sensex's 7.77%, highlighting the market's lack of confidence in its..."
      },
      {
        "title": "Is Dev Labtech overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-dev-labtech-overvalued-or-undervalued-3645408",
        "imagepath": "",
        "date": "2025-10-25 08:05:49",
        "description": "As of 24 October 2025, the valuation grade for Dev Labtech has moved from fair to expensive, indicating a shift in perception regarding its market value. The company is currently considered overvalued. Key ratios include a PE ratio of 56.15, an EV to EBITDA ratio of 23.92, and a ROCE of 4.75%. \n\nIn comparison to its peers, Dev Labtech's PE ratio is significantly higher than that of PC Jeweller, which stands at 13.23, and P N Gadgil Jewellers at 36.2. This disparity suggests that Dev Labtech is priced at a premium relative to its competitors in the gems and jewellery industry. Additionally, the company's stock has underperformed against the Sensex, with a year-to-date return of -20.7% compared to the Sensex's 7.77%, reinforcing the notion that the stock may be overvalued at its current price of 61.06...."
      },
      {
        "title": "Why is Dev Labtech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dev-labtech-fallingrising-3596910",
        "imagepath": "",
        "date": "2025-10-06 23:32:49",
        "description": "As of 06-Oct, Dev Labtech Venture Ltd is experiencing a decline in its stock price, currently at Rs 60.11, which reflects a decrease of Rs 2.09 or 3.36%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 6.08% over the past week. Additionally, the stock opened with a loss today and has not shown any price range movement, remaining at the same price throughout the trading session. It is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Furthermore, there has been a significant drop in investor participation, with delivery volume decreasing by 34.78% compared to the 5-day average, which suggests a lack of confidence among investors.\n\nIn the broader market context, the stock's performance has been notably poor compared to the Sensex, which has gained 1.77% over the past week. Year-..."
      },
      {
        "title": "Why is Dev Labtech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dev-labtech-fallingrising-3523009",
        "imagepath": "",
        "date": "2025-09-16 23:25:58",
        "description": "As of 16-Sep, Dev Labtech Venture Ltd's stock price is currently at Rs 66.00, reflecting a decline of Rs 2.64 or 3.85%. The stock has underperformed its sector by 4.49% today and has experienced a trend reversal, falling after two consecutive days of gains. It opened with a loss of 2.39% and reached an intraday low of Rs 66. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 66.67% compared to the 5-day average. The stock has also shown poor performance over various periods, with a year-to-date decline of 14.29% and a one-year decline of 21.05%, while the benchmark Sensex has gained 5.43% and is down only 0.73% over the same period.\n\nIn the broader market context, the stock's short-term performance has been notably weaker than the Sen..."
      }
    ],
    "total": 63,
    "sid": "1003820",
    "stock_news_url": "https://www.marketsmojo.com/news/dev-labtech-venture-1003820"
  },
  "announcements": [
    {
      "caption": "Statement On Deviation Or Variation Of Funds Raised Through The Preferential Issue.",
      "datetime": "12-Nov-2025",
      "details": "Statement on Deviation or Variation of funds raised through the Preferential Issue.",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Standalone And Consolidated Financial Results For The Half Year Ended 30Th September 2025 Along With Limited Review Report Of Statutory Auditor.",
      "datetime": "12-Nov-2025",
      "details": "Unaudited Standalone & Consolidated Financial Result for the Half Year ended 30.09.2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Registered Office Address",
      "datetime": "12-Nov-2025",
      "details": "Change of Registered Office of the Company w.e.f. 15.11.2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Is Dev Labtech overvalued or undervalued?

2025-11-27 08:51:58

Valuation Metrics Indicate Elevated Pricing

Dev Labtech’s price-to-earnings (PE) ratio stands at an elevated 71.55, significantly higher than the broader market average and many of its industry peers. This high PE ratio suggests that investors are pricing in substantial future growth or are willing to pay a premium for the company’s earnings potential. However, such a lofty multiple also raises concerns about overvaluation, especially when juxtaposed with the company’s modest return on capital employed (ROCE) of 4.35% and return on equity (ROE) of 2.92%, which are relatively low for a firm commanding such a premium.

The price-to-book (P/B) value of 2.09 further supports the notion that the stock is trading well above its net asset value. Additionally, enterprise value ...

Read More

Why is Dev Labtech falling/rising?

2025-11-22 01:29:52

Recent Price Movement and Market Context

Dev Labtech's share price increase on 21-Nov reflects a broader trend of strong short-term gains. Over the past week, the stock has surged by 10.96%, significantly outpacing the Sensex's modest 0.79% rise during the same period. This outperformance extends to the one-month horizon, where Dev Labtech has appreciated by 13.18%, compared to the Sensex's 0.95% gain. Despite these encouraging short-term returns, the stock remains in negative territory year-to-date, down 11.81%, and has experienced a 19.01% decline over the last year, contrasting with the Sensex's positive returns of 9.08% and 10.47% respectively. This divergence highlights the stock's recent recovery phase amid a longer-term correction.

Technical Indicators a...

Read More
stock-recommendationAnnouncement

Statement On Deviation Or Variation Of Funds Raised Through The Preferential Issue.

12-Nov-2025 | Source : BSE

Statement on Deviation or Variation of funds raised through the Preferential Issue.

Unaudited Standalone And Consolidated Financial Results For The Half Year Ended 30Th September 2025 Along With Limited Review Report Of Statutory Auditor.

12-Nov-2025 | Source : BSE

Unaudited Standalone & Consolidated Financial Result for the Half Year ended 30.09.2025.

Announcement under Regulation 30 (LODR)-Change in Registered Office Address

12-Nov-2025 | Source : BSE

Change of Registered Office of the Company w.e.f. 15.11.2025

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available